Having trouble accessing articles? Reset your cache.

Nitisinone: Phase I data

An open-label Phase I trial in 14 patients showed that SYN-118 was well tolerated and significantly improved motor

Read the full 187 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE